WuXi AppTec (OTCMKTS:WUXAY) Trading Down 4.3% – Here’s What Happened

WuXi AppTec Co., Ltd. (OTCMKTS:WUXAY) shares fell 4.3% on Monday . The company traded as low as $15.99 and last traded at $15.99. 201 shares changed hands during mid-day trading, a decline of 89% from the average session volume of 1,812 shares. The stock had previously closed at $16.7132.

Wall Street Analyst Weigh In

A number of equities research analysts have recently commented on WUXAY shares. Zacks Research upgraded WuXi AppTec to a “hold” rating in a research report on Monday, April 13th. The Goldman Sachs Group raised shares of WuXi AppTec to a “buy” rating in a report on Thursday, February 5th. One investment analyst has rated the stock with a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat.com, WuXi AppTec currently has an average rating of “Moderate Buy”.

WuXi AppTec Stock Performance

The firm’s 50 day simple moving average is $15.71 and its 200-day simple moving average is $14.60.

WuXi AppTec (OTCMKTS:WUXAY) last posted its quarterly earnings results on Monday, April 27th. The company reported $0.23 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.18 by $0.05. The company had revenue of $1.82 billion during the quarter, compared to analysts’ expectations of $1.59 billion.

WuXi AppTec Company Profile

WuXi AppTec is a global contract research, development and manufacturing organization serving the pharmaceutical, biotechnology and medical device industries. Headquartered in Shanghai and founded in 2000, the company provides end-to-end solutions that span drug discovery, development and manufacturing. Its offerings enable customers to accelerate the research and development process for small molecules, biologics, cell and gene therapies, as well as medical devices.

Key services include chemistry and biology discovery support, preclinical safety assessment, analytical and formulation development, clinical manufacturing, large-scale biomanufacturing, and quality testing.